 | • レポートコード：MRC2-11QY11355 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は軟骨肉腫治療のグローバル市場について調査・分析したレポートです。種類別（外科的治療、化学療法、放射線療法）市場規模、用途別（病院、専門クリニック、がん治療センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別軟骨肉腫治療の競争状況、市場シェア ・世界の軟骨肉腫治療市場：種類別市場規模 2015年-2020年（外科的治療、化学療法、放射線療法） ・世界の軟骨肉腫治療市場：種類別市場規模予測 2021年-2026年（外科的治療、化学療法、放射線療法） ・世界の軟骨肉腫治療市場：用途別市場規模 2015年-2020年（病院、専門クリニック、がん治療センター） ・世界の軟骨肉腫治療市場：用途別市場規模予測 2021年-2026年（病院、専門クリニック、がん治療センター） ・北米の軟骨肉腫治療市場分析：米国、カナダ ・ヨーロッパの軟骨肉腫治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの軟骨肉腫治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の軟骨肉腫治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの軟骨肉腫治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Hoffmann-La Roche、AEterna Zentaris、Acorn Research、Agios Pharmaceuticals、Infinity Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Chondrosarcoma refers to cancer of cartilage, a flexible connective tissue found in joints between bones, the ear, the rib cage etc. According to Cancer Network Journal, chondrosarcoma contributes to almost half of the osteosarcoma cases and is the second most common type of osteosacrcoma (tumor of bones). Chondrosarcoma can start at any age but most commonly found in adults above the age of 20 years. As per the statistics of American Cancer Society, occurrence of chondrosarcoma in patients younger than 20 years is less than 5%. Chondrosarcoma mainly affects the cartilage of arms, ribs, pelvis, and scapula and rarely found in trachea, breast and other parts of the body showing presence of cartilage tissue. Chondrosarcoma patients do not show any symptoms at an early stage hence, it can only be diagnosed in the late stage of a tumor when it shows fracture and bony bump at the tumor site. Diagnosis of chondrosarcoma can be done using radiography (X-Ray), computerized tomography (CT scan) or magnetic resonance imaging (MRI). Unlike other cancers chondrosarcoma is resistant to chemotherapy and radiation therapy and can primarily be treated with surgery. Surgical procedures for chondrosarcoma treatment involve limb sparing operations, complete surgical ablation and amputation in certain cases.
Increasing prevalence of osteosarcoma can ultimately influence the growth of global chondrosarcoma treatment market. According to Cancer Network Journal the incidence of osteosacrcoma in the U.S. is approximately 800 cases per year. Other factors responsible for growth of global chondrosarcoma treatment market include growing prevalence of genetic diseases.
Market Analysis and Insights: Global Chondrosarcoma Treatment Market
The global Chondrosarcoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Chondrosarcoma Treatment Scope and Market Size
Chondrosarcoma Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chondrosarcoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Hoffmann-La Roche
AEterna Zentaris
Acorn Research
Agios Pharmaceuticals
Infinity Pharmaceuticals
…
Market segment by Type, the product can be split into
Surgical Treatment
Chemotherapy
Radiation Therapy
Market segment by Application, split into
Hospitals
Multispecialty Clinics
Cancer Treatment Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Chondrosarcoma Treatment Revenue
1.4 Market by Type
1.4.1 Global Chondrosarcoma Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Surgical Treatment
1.4.3 Chemotherapy
1.4.4 Radiation Therapy
1.5 Market by Application
1.5.1 Global Chondrosarcoma Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Multispecialty Clinics
1.5.4 Cancer Treatment Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Chondrosarcoma Treatment Market Perspective (2015-2026)
2.2 Global Chondrosarcoma Treatment Growth Trends by Regions
2.2.1 Chondrosarcoma Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Chondrosarcoma Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Chondrosarcoma Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Chondrosarcoma Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Chondrosarcoma Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Chondrosarcoma Treatment Players by Market Size
3.1.1 Global Top Chondrosarcoma Treatment Players by Revenue (2015-2020)
3.1.2 Global Chondrosarcoma Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Chondrosarcoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Chondrosarcoma Treatment Market Concentration Ratio
3.2.1 Global Chondrosarcoma Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Chondrosarcoma Treatment Revenue in 2019
3.3 Chondrosarcoma Treatment Key Players Head office and Area Served
3.4 Key Players Chondrosarcoma Treatment Product Solution and Service
3.5 Date of Enter into Chondrosarcoma Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Chondrosarcoma Treatment Historic Market Size by Type (2015-2020)
4.2 Global Chondrosarcoma Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Chondrosarcoma Treatment Market Size by Application (2015-2020)
5.2 Global Chondrosarcoma Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Chondrosarcoma Treatment Market Size (2015-2020)
6.2 Chondrosarcoma Treatment Key Players in North America (2019-2020)
6.3 North America Chondrosarcoma Treatment Market Size by Type (2015-2020)
6.4 North America Chondrosarcoma Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Chondrosarcoma Treatment Market Size (2015-2020)
7.2 Chondrosarcoma Treatment Key Players in Europe (2019-2020)
7.3 Europe Chondrosarcoma Treatment Market Size by Type (2015-2020)
7.4 Europe Chondrosarcoma Treatment Market Size by Application (2015-2020)
8 China
8.1 China Chondrosarcoma Treatment Market Size (2015-2020)
8.2 Chondrosarcoma Treatment Key Players in China (2019-2020)
8.3 China Chondrosarcoma Treatment Market Size by Type (2015-2020)
8.4 China Chondrosarcoma Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Chondrosarcoma Treatment Market Size (2015-2020)
9.2 Chondrosarcoma Treatment Key Players in Japan (2019-2020)
9.3 Japan Chondrosarcoma Treatment Market Size by Type (2015-2020)
9.4 Japan Chondrosarcoma Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Chondrosarcoma Treatment Market Size (2015-2020)
10.2 Chondrosarcoma Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Chondrosarcoma Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Chondrosarcoma Treatment Market Size by Application (2015-2020)
11 India
11.1 India Chondrosarcoma Treatment Market Size (2015-2020)
11.2 Chondrosarcoma Treatment Key Players in India (2019-2020)
11.3 India Chondrosarcoma Treatment Market Size by Type (2015-2020)
11.4 India Chondrosarcoma Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Chondrosarcoma Treatment Market Size (2015-2020)
12.2 Chondrosarcoma Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Chondrosarcoma Treatment Market Size by Type (2015-2020)
12.4 Central & South America Chondrosarcoma Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Hoffmann-La Roche
13.1.1 Hoffmann-La Roche Company Details
13.1.2 Hoffmann-La Roche Business Overview
13.1.3 Hoffmann-La Roche Chondrosarcoma Treatment Introduction
13.1.4 Hoffmann-La Roche Revenue in Chondrosarcoma Treatment Business (2015-2020))
13.1.5 Hoffmann-La Roche Recent Development
13.2 AEterna Zentaris
13.2.1 AEterna Zentaris Company Details
13.2.2 AEterna Zentaris Business Overview
13.2.3 AEterna Zentaris Chondrosarcoma Treatment Introduction
13.2.4 AEterna Zentaris Revenue in Chondrosarcoma Treatment Business (2015-2020)
13.2.5 AEterna Zentaris Recent Development
13.3 Acorn Research
13.3.1 Acorn Research Company Details
13.3.2 Acorn Research Business Overview
13.3.3 Acorn Research Chondrosarcoma Treatment Introduction
13.3.4 Acorn Research Revenue in Chondrosarcoma Treatment Business (2015-2020)
13.3.5 Acorn Research Recent Development
13.4 Agios Pharmaceuticals
13.4.1 Agios Pharmaceuticals Company Details
13.4.2 Agios Pharmaceuticals Business Overview
13.4.3 Agios Pharmaceuticals Chondrosarcoma Treatment Introduction
13.4.4 Agios Pharmaceuticals Revenue in Chondrosarcoma Treatment Business (2015-2020)
13.4.5 Agios Pharmaceuticals Recent Development
13.5 Infinity Pharmaceuticals
13.5.1 Infinity Pharmaceuticals Company Details
13.5.2 Infinity Pharmaceuticals Business Overview
13.5.3 Infinity Pharmaceuticals Chondrosarcoma Treatment Introduction
13.5.4 Infinity Pharmaceuticals Revenue in Chondrosarcoma Treatment Business (2015-2020)
13.5.5 Infinity Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Chondrosarcoma Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Chondrosarcoma Treatment Revenue
Table 3. Ranking of Global Top Chondrosarcoma Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Chondrosarcoma Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Surgical Treatment
Table 6. Key Players of Chemotherapy
Table 7. Key Players of Radiation Therapy
Table 8. Global Chondrosarcoma Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Chondrosarcoma Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Chondrosarcoma Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Chondrosarcoma Treatment Market Share by Regions (2015-2020)
Table 12. Global Chondrosarcoma Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Chondrosarcoma Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Chondrosarcoma Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Chondrosarcoma Treatment Players
Table 19. Global Chondrosarcoma Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Chondrosarcoma Treatment Market Share by Players (2015-2020)
Table 21. Global Top Chondrosarcoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chondrosarcoma Treatment as of 2019)
Table 22. Global Chondrosarcoma Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Chondrosarcoma Treatment Product Solution and Service
Table 25. Date of Enter into Chondrosarcoma Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Chondrosarcoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Chondrosarcoma Treatment Market Size Share by Type (2015-2020)
Table 29. Global Chondrosarcoma Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Chondrosarcoma Treatment Market Size Share by Application (2015-2020)
Table 31. Global Chondrosarcoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Chondrosarcoma Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Chondrosarcoma Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Chondrosarcoma Treatment Market Share (2019-2020)
Table 35. North America Chondrosarcoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Chondrosarcoma Treatment Market Share by Type (2015-2020)
Table 37. North America Chondrosarcoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Chondrosarcoma Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Chondrosarcoma Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Chondrosarcoma Treatment Market Share (2019-2020)
Table 41. Europe Chondrosarcoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Chondrosarcoma Treatment Market Share by Type (2015-2020)
Table 43. Europe Chondrosarcoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Chondrosarcoma Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Chondrosarcoma Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Chondrosarcoma Treatment Market Share (2019-2020)
Table 47. China Chondrosarcoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Chondrosarcoma Treatment Market Share by Type (2015-2020)
Table 49. China Chondrosarcoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Chondrosarcoma Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Chondrosarcoma Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Chondrosarcoma Treatment Market Share (2019-2020)
Table 53. Japan Chondrosarcoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Chondrosarcoma Treatment Market Share by Type (2015-2020)
Table 55. Japan Chondrosarcoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Chondrosarcoma Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Chondrosarcoma Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Chondrosarcoma Treatment Market Share (2019-2020)
Table 59. Southeast Asia Chondrosarcoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Chondrosarcoma Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Chondrosarcoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Chondrosarcoma Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Chondrosarcoma Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Chondrosarcoma Treatment Market Share (2019-2020)
Table 65. India Chondrosarcoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Chondrosarcoma Treatment Market Share by Type (2015-2020)
Table 67. India Chondrosarcoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Chondrosarcoma Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Chondrosarcoma Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Chondrosarcoma Treatment Market Share (2019-2020)
Table 71. Central & South America Chondrosarcoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Chondrosarcoma Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Chondrosarcoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Chondrosarcoma Treatment Market Share by Application (2015-2020)
Table 75. Hoffmann-La Roche Company Details
Table 76. Hoffmann-La Roche Business Overview
Table 77. Hoffmann-La Roche Product
Table 78. Hoffmann-La Roche Revenue in Chondrosarcoma Treatment Business (2015-2020) (Million US$)
Table 79. Hoffmann-La Roche Recent Development
Table 80. AEterna Zentaris Company Details
Table 81. AEterna Zentaris Business Overview
Table 82. AEterna Zentaris Product
Table 83. AEterna Zentaris Revenue in Chondrosarcoma Treatment Business (2015-2020) (Million US$)
Table 84. AEterna Zentaris Recent Development
Table 85. Acorn Research Company Details
Table 86. Acorn Research Business Overview
Table 87. Acorn Research Product
Table 88. Acorn Research Revenue in Chondrosarcoma Treatment Business (2015-2020) (Million US$)
Table 89. Acorn Research Recent Development
Table 90. Agios Pharmaceuticals Company Details
Table 91. Agios Pharmaceuticals Business Overview
Table 92. Agios Pharmaceuticals Product
Table 93. Agios Pharmaceuticals Revenue in Chondrosarcoma Treatment Business (2015-2020) (Million US$)
Table 94. Agios Pharmaceuticals Recent Development
Table 95. Infinity Pharmaceuticals Company Details
Table 96. Infinity Pharmaceuticals Business Overview
Table 97. Infinity Pharmaceuticals Product
Table 98. Infinity Pharmaceuticals Revenue in Chondrosarcoma Treatment Business (2015-2020) (Million US$)
Table 99. Infinity Pharmaceuticals Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chondrosarcoma Treatment Market Share by Type: 2020 VS 2026
Figure 2. Surgical Treatment Features
Figure 3. Chemotherapy Features
Figure 4. Radiation Therapy Features
Figure 5. Global Chondrosarcoma Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Multispecialty Clinics Case Studies
Figure 8. Cancer Treatment Centers Case Studies
Figure 9. Chondrosarcoma Treatment Report Years Considered
Figure 10. Global Chondrosarcoma Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Chondrosarcoma Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Chondrosarcoma Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Chondrosarcoma Treatment Market Share by Players in 2019
Figure 15. Global Top Chondrosarcoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chondrosarcoma Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Chondrosarcoma Treatment Revenue in 2019
Figure 17. North America Chondrosarcoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Chondrosarcoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Chondrosarcoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Chondrosarcoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Chondrosarcoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Chondrosarcoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Chondrosarcoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
転移性がん治療の世界市場（～2026年） Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…- 非血液がん治療の世界市場（～2026年） Non-Hematological cancers which cover lung cancer, prostate cancer, breast cancer and others, this type of cancer are not show easily diagnosis and the treatment process is also show long that some time it lead to the death of the patient. North America has the huge number of population suffering fr…
- 非黒色腫皮膚がん治療の世界市場（～2026年） Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts. Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlike…
- 甲状腺がん治療の世界市場（～2026年） Market Analysis and Insights: Global Thyroid Cancer Treatment Market The global Thyroid Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Thyroid Cancer Treatment Scope and Market Size Thyroid Cancer Tre…
- 去勢抵抗性前立腺がん治療の世界市場（～2026年） Prostate cancer can be defined as it is a form of cancer that develops into male reproductive system. Most of the prostate cancer are slow growing and stable but sometimes it can spread from prostate (gland) to other part of body such as bone and lymph node. Initially prostate cancer does not pose a…